Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias
Franco Locatelli(Bambino Gesù Children's Hospital), Neena Kapoor(University of Southern California), Swati Naik(St. Jude Children's Research Hospital), Waseem Qasim(University College London), Pietro Merli(Children's Hospital of Philadelphia), Deepa Manwani(Albert Einstein College of Medicine), Melissa Kuhn(Bellicum Pharmaceuticals (United States)), David A. Jacobsohn(Children's National), Annalisa Ruggeri(Inserm), Victor Aquino(The University of Texas Southwestern Medical Center), Rajni Agarwal(Regenerative Medicine Institute), Lakshmanan Krishnamurti(Emory University), Eneida R. Nemecek(Oregon Health & Science University)
Cited by 4
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738